Poractant Alfa
3 brands · 2 companies · product forms
Opportunity snapshot
Who competes here
Top companies by brand count — concentrated market · leader share 67%
Price room
max/min price ratio 1.56x across 4 trusted points (Rs 37392.0-58245.0). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.
Brands & products on the market
Sample of 2 live products for Poractant Alfa — each links to its own medicine page.
Regulatory alerts
Why this score
Launch attractiveness
40% supply-gap(60) + 25% price-variation(14) + 20% low-competition(95) + 15% supply-disruption(40), damped by confidence(90). Higher = more attractive, less crowded opportunity.
Market saturation
2 canonical companies and 3 brands compete (saturation pegged at 30 companies / 150 brands).
Price room
max/min price ratio 1.56x across 4 trusted points (Rs 37392.0-58245.0). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.
Regulatory risk
1 DRAP alert(s), latest 2026-04-14 incl. recall/safety.
Confidence
Reduced by: no ATC code.
Packaged brief for this strong opportunity?
Molecule page + company profiles + price-room analysis are the pilot package for pharma teams.
See packaged reports All 3868 molecules